Physiomics (LON:PYC) Shares Down 11.2% – Here’s Why

Physiomics Plc (LON:PYC)’s share price traded down 11.2% during mid-day trading on Thursday . The company traded as low as GBX 0.44 and last traded at GBX 0.44. 871,681 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 6,996,127 shares. The stock had previously closed at GBX 0.50.

Physiomics Stock Down 11.2%

The firm has a 50-day moving average price of GBX 0.40 and a two-hundred day moving average price of GBX 0.40. The firm has a market cap of £1.35 million, a PE ratio of -2.61 and a beta of 1.69.

Physiomics (LON:PYC) last announced its quarterly earnings results on Monday, February 16th. The company reported GBX (0.10) earnings per share for the quarter. Physiomics had a negative net margin of 50.92% and a negative return on equity of 89.43%. Research analysts forecast that Physiomics Plc will post -0.13 earnings per share for the current fiscal year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.